Combination Chemotherapy and Imatinib Mesylate in Treating Children With Relapsed Acute Lymphoblastic Leukemia

Clinical trial NCT00049569 · COMPLETED

Trial details

NCT number: NCT00049569
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

L1 Childhood Acute Lymphoblastic Leukemia L2 Childhood Acute Lymphoblastic Leukemia Non-T, Non-B Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia T-cell Childhood Acute Lymphoblastic Leukemia

Start date: 2003-01-01
Primary completion: 2006-03-01
Enrollment: 126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.